Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-7479d7b7d-fwgfc Total loading time: 0 Render date: 2024-07-11T01:48:05.233Z Has data issue: false hasContentIssue false

8 - The metabolic disease autopsy

Published online by Cambridge University Press:  05 September 2014

By
Kevin Bove  and
Simon Olpin
Edited by
Marta C. Cohen  and
Irene Scheimberg
Kevin Bove
Affiliation:
University of Cincinnati College of Medicine
Simon Olpin
Affiliation:
Sheffield Children’s Hospital, Sheffield, UK
Marta C. Cohen
Affiliation:
Sheffield Children’s Hospital
Irene Scheimberg
Affiliation:
Barts and the London NHS Trust, London
Get access

Summary

Introduction

When an infant or young child dies suddenly or after a brief hospitalization, without a specific diagnosis, and is suspected by the clinician to have a metabolic disease, an important question for the pathologist is which investigations to pursue as part of the autopsy. In this situation, both the clinician and the pathologist are seriously disadvantaged. Many metabolic diseases evolve slowly, meaning time is needed for recognition followed by thoughtful disease-focused ante-mortem diagnostic testing. When this luxury has been preempted by circumstances, the quest for understanding the biological basis for a seemingly inexplicable death is not hopeless. In fact, the possibility for success using modern tools has never been greater.

To determine how to proceed, a pre-autopsy discussion between the pathologist and the clinician is essential. Issues of cost and reimbursement eventually emerge, but this can be managed by making choices focused and dictated by the situation at hand in order to have the greatest chance of success. The essential components of a systematic assessment reside in the details of clinical presentation, the family history, the available ante-mortem laboratory data, and the gross and microscopic findings. This information will influence the details of specimen collection and guide subsequent decisions about testing.

Type
Chapter
Information
The Pediatric and Perinatal Autopsy Manual , pp. 120 - 138
Publisher: Cambridge University Press
Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Arens, R., Gozel, D., Jain, K., et al. Prevalence of medium-chain dehydrogenase deficiency in sudden infant death syndrome. J Pediatr 1993; 122: 715–18.CrossRefGoogle ScholarPubMed
Bennett, M. J., Rinaldo, P., and Strauss, A. W.. Inborn errors of mitochondrial fatty acid oxidation. Crit Rev Clin Lab Sci 2000; 37: 1–44.CrossRefGoogle ScholarPubMed
Bennett, M. J., and Rinaldo, P.. The metabolic autopsy comes of age. Clin Chem 2001; 47: 1145–6.Google ScholarPubMed
Boles, R. G., Buck, E. A., Blitzer, M. G., et al. Retrospective biochemical screening of fatty acid oxidation disorders in post-mortem livers of 418 cases of sudden death in the first year of life. J Pediatr 1998; 132: 924–33.CrossRefGoogle Scholar
Leonard, J. V. and Morris, A. A. M.. Inborn errors of metabolism around the time of birth. Lancet 2000; 356: 583–7.CrossRefGoogle ScholarPubMed
Ernst, L. M., Sondheimer, N., Deardorff, M. A., Bennett, M. J., and Pawel, B. R.. The value of the metabolic autopsy in the paediatric hospital setting. J Pediatr 2006; 148: 779–83.CrossRefGoogle Scholar
Hudak, M. L., Jones, M. D., and Brusilow, S. W.. Differentiation of transient hyperammonaemia of the newborn and urea cycle enzyme defects by clinical presentation. J Pediatr 1985; 107: 712–19.CrossRefGoogle ScholarPubMed
Lafolla, A. K., Thompson, Jr R. J., Roe, C. R.. Medium-chain acyl-CoA dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 1994; 124: 409–15.CrossRefGoogle Scholar
Maestri, N. E., Clissold, D. B., and Brusilow, S. W.. Neonatal onset ornithine transcarbamylase deficiency: a retrospective analysis. J Pediatr 1999; 134: 268–72.CrossRefGoogle ScholarPubMed
Ruitenbeek, W., Poelis, P. J., Turnbull, D. M., et al. Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency. J Neurol Neurosurg Psychiatry 1995; 58: 209–14.CrossRefGoogle ScholarPubMed
Munnich, A., Rotig, A., Cormier-Daire, V., and Rustin, P.. Clinical presentation of respiratory chain deficiency. In: Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., eds., The Metabolic and Molecular Basis of Inherited Disease. 8th edition. New York, McGraw-Hill, 2000, 2261–74.Google Scholar
Paterson, C. R., Burns, J., and McAllion, S. J.. Osteogenesis imperfecta: the distinction from child abuse and the recognition of a variant form. Am J Med Genet 1993; 45: 187–92.CrossRefGoogle ScholarPubMed
Hartley, L. M., Khwaja, O. S., and Verity, C. M.. Glutaric aciduria type I and non-accidental head injury. Pediatr 2001; 107: 174–5.CrossRefGoogle Scholar
Marlowe, A., Pepin, M. G., and Byers, P. H.. Testing for Osteogenesis Imperfecta in cases of non-accidental injury. J Med Genet 2002; 39: 382–6.CrossRefGoogle ScholarPubMed
Nassogne, M.-C., Sharrard, M., Hertz-Pannier, L., et al. Massive subdural haematomas in Menkes disease mimicking shaken baby syndrome. Childs Nerv Syst 2002; 18: 729–31.CrossRefGoogle ScholarPubMed
Wilkins, B.. Head injury: abuse or accident?Arch Dis Child 1997; 76: 393–7.CrossRefGoogle ScholarPubMed
Chace, D. H., DiPerna, J. C., Mitchell, B. L., et al. Electrospray tandem mass spectrometry for acylcarnitines in dried post mortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem 2001; 47: 1166–82.Google Scholar
Saudubray, J. M., Martin, D., de Lonlay, P., et al. Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inher Metab Dis 1999; 22: 448–502.CrossRefGoogle ScholarPubMed
Olpin, S. E. and Evans, M.-J.. Investigations of inherited metabolic disease after death. In Rutty, G. N., ed., Essentials of Autopsy Practice: Recent Advances, Topics and Developments. London, Springer-Verlag, 2004, 17–44.CrossRefGoogle Scholar
Olpin, S. E., Manning, N. J., Pollitt, R. J., et al. The use of [9,10−3 H]myristate, [9,10−3 H]palmitate and [9,10−3 H]oleate for the detection and diagnosis of medium and long-chain fatty acid oxidation disorders in intact cultured fibroblasts. In: Quant, P. A. and Eaton, S., eds., Current Views of Fatty Acid Oxidation and Ketogenesis (Proceedings of the 4th International Symposium on Fatty Acid Oxidation). New York, Plenum Press, 1999, 321–5.Google Scholar
Olpin, S. E., Metabolic investigations of sudden infant death. Ann Clin Biochem 2004; 41: 1–12.CrossRefGoogle ScholarPubMed
Olpin, S. E.Sudden unexplained neonatal death – metabolic autopsy. In: Anil, B., ed., Inborn Errors of Metabolism in Critically Ill Newborns. New Delhi, Noble Vision, 2012, chapter 10.Google Scholar
Rinaldo, P., Yoon, H. R., Yu, C., et al. Sudden and unexpected neonatal death: protocol for the post mortem diagnosis of fatty acid oxidation disorders. Semin Perinatol 1999; 23: 204–10.CrossRefGoogle Scholar
Roe, C. R. and Roe, D. S.. Recent developments in the investigation of inherited metabolic disorders using cultured human cells. Mol Genet Metab 1999; 68: 243–57.CrossRefGoogle ScholarPubMed
Calvo, S. E., Compton, A. G., Hershman, S. G., et al. Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Transl Med 2012; 4: 118.CrossRefGoogle ScholarPubMed
Lang, T. F.. Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD). J Inherit Metab Dis 2009; 32: 675–83.CrossRefGoogle Scholar
Nada, M. A., Rhead, W. J., Sprecher, H., Schulz, H., and Roe, C. R.. Evidence for intermediate channeling in mitochondrial beta-oxidation. J Biol Chem 1995; 270: 530–5.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×